Physician profile
Roy D Nini
NPI 1679633960
$6,042.25
in general payments reported to CMS, 2019-2025
22 companies · $676 in 2025
The $676 reported for 2025 was more than what 88% of Sports Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,901 · 2020: $280 · 2021: $274 · 2022: $854 · 2023: $1,259 · 2024: $799 · 2025: $676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,733.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,051.34 | 2021-2025 | Intellis Adaptivestim, Accurian, Inceptiv |
| Medtronic USA, INC. | $1,106.15 | 2019-2020 | |
| Electronic Waveform Lab, INC. | $596.85 | 2022-2025 | |
| Merz North America, INC. | $446.46 | 2019-2020 | |
| Merz Pharmaceuticals, LLC | $440.16 | 2021-2025 | Xeomin |
| Nalu Medical, INC. | $289.54 | 2021-2024 | Nalu Neurostimulation System |
| Mml US, INC. | $206.66 | 2023 | Reactiv8 |
| Boston Scientific Corporation | $199.08 | 2019-2025 | Intracept, Infinion 16 |
| Abbott Laboratories | $173.83 | 2019-2023 | Proclaim |
| Spinesmith Holdings, LLC | $102.07 | 2019 | |
| Zimmer Biomet Holdings, INC. | $93.24 | 2019-2020 | |
| Vertos Medical, INC. | $88.52 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.57 | 2020-2021 | |
| Ermi LLC | $35.01 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $30.08 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $27.30 | 2022 | |
| Daiichi Sankyo INC. | $26.18 | 2019 | |
| Depuy Synthes Sales INC. | $25.06 | 2024 | Monovisc |
| Pacira Therapeutics, INC. | $20.55 | 2019 | |
| Avanos Medical | $16.10 | 2023 | Trivisc Sodium Hyaluronate |
| Metacel Pharmaceuticals LLC | $15.34 | 2023 | Ozobax |
| Nevro Corp. | $12.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Nini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.